A demonstration program that provides up to eight tests per beneficiary per month is set to lift on 11 May, leaving some concerned about test access for beneficiaries.
Medicare beneficiaries will no longer be eligible for no-cost over-the-counter COVID-19 test kits after the public health emergency (PHE) ends on 11 May, the US Centers for Medicare and Medicaid Services announced on 1 May.
People with Medicare Part B are eligible for up to eight OTC tests per month under a demonstration project that’s been running since 4 April 2022. But that project is...
Medtronic’s diabetes spin-out – a process likely to run up to 18 months and involve 20% IPO followed by a split-off for Medtronic shareholders – will allow firm to focus on higher-margin devices.
Now that the landmark Pandemic Agreement has finally been adopted, work will start on drafting a pathogen access and benefit sharing system that will be voluntary for use by drug companies.
TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.
